Mustang Bio Inc. (MBIO)
NASDAQ: MBIO
· Real-Time Price · USD
1.52
-0.15 (-8.98%)
At close: Oct 16, 2025, 3:59 PM
1.52
0.00%
After-hours: Oct 16, 2025, 07:42 PM EDT
-8.98% (1D)
| Bid | 1.48 |
| Market Cap | 11.01M |
| Revenue (ttm) | 1.99M |
| Net Income (ttm) | -3.28M |
| EPS (ttm) | 1.99 |
| PE Ratio (ttm) | 0.76 |
| Forward PE | -0.02 |
| Analyst | n/a |
| Dividends | n/a |
| Ask | 1.56 |
| Volume | 262,109 |
| Avg. Volume (20D) | 168,971 |
| Open | 1.67 |
| Previous Close | 1.67 |
| Day's Range | 1.47 - 1.68 |
| 52-Week Range | 0.89 - 21.95 |
| Beta | 2.30 |
| Ex-Dividend Date | n/a |
About MBIO
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol MBIO
Website n/a
3 months ago
+180.67%
Mustang Bio shares are trading higher after the co...
Unlock content with
Pro Subscription
3 months ago
+114.64%
Mustang Bio shares are trading higher after the company announced it received FDA Orphan Drug designation status for MB-101.
